ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.042,00
0,18%
S&P 500
6.049,24
0,88%
Dow Jones
44.025,81
1,24%
Euro vs US Dollar
1,04155
0,10%
Bitcoin
105.114,26
-1,00%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Pliant Therapeutics Inc (PLRX) Börsenkurse

Pliant Therapeutics Inc

Pliant Therapeutics Inc (PLRX)

NASDAQ
11,07
-0,14
(-1,25%)
Geschlossen 22 Januar 10:00PM
Verzögert um 15 Minuten
11,07
-0,02
(-0,18%)
Nach Börsenschluss: 11:37PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
11,07
Gebot
10,22
Fragen
14,00
Volumen
680.658
11,04 Tagesbereich 11,3967
10,22 52-Wochen-Bereich 18,9199
Marktkapitalisierung
673,65M
Handelsende
11,21
Handelsbeginn
11,07
Letzte Trade
1
@
11.2
Letzter Handelszeitpunkt
Finanzvolumen
US$ 7.610.631
VWAP
11,1813
Durchschnittliches Volumen (3 Mio.)
513.406
Ausgegebene Aktien
60.853.623
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-4,18
Gewinn pro Aktie (EPS)
-2,65
Erlöse
1,58M
Nettogewinn
-161,34M

Über Pliant Therapeutics Inc

Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
pliantrx.com.
Hauptsitz
Dover, Delaware, USA
Gegründet
-
Pliant Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PLRX. The last closing price for Pliant Therapeutics was US$11,21. Over the last year, Pliant Therapeutics shares have traded in a share price range of US$ 10,22 to US$ 18,9199.

Pliant Therapeutics currently has 60.853.623 shares in issue. The market capitalisation of Pliant Therapeutics is US$682,17 million. Pliant Therapeutics has a price to earnings ratio (PE ratio) of -4.18.

PLRX Neueste Nachrichten

Weitere Nachrichten

Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that Bernard Coulie, M.D., Ph.D., President and Chief Executive Officer...

02 Januar 2025
GlobeNewswire Inc.

Pliant Therapeutics to Participate in Upcoming Investor Events

SOUTH SAN FRANCISCO, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of...

21 November 2024
GlobeNewswire Inc.

Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024

INTEGRIS-PSC featured in an oral late breaker presentation SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology...

19 November 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 November 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 November 2024
Edgar (US Regulatory)

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

BEACON-IPF Phase 2b trial on track for full enrollment in the first quarter of 2025 with data anticipated in mid-2026 SOUTH SAN FRANCISCO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pliant...

07 November 2024
GlobeNewswire Inc.

Pliant Therapeutics to Participate in the Stifel Healthcare Conference

SOUTH SAN FRANCISCO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that Keith Cummings, M.D., Chief Financial Officer, and Greg Cosgrove, M.D. FCCP...

06 November 2024
GlobeNewswire Inc.

Pliant Therapeutics INTEGRIS-PSC Phase 2a Data Evaluating Bexotegrast in Primary Sclerosing Cholangitis to be Highlighted in a Late-Breaking Presentation at The Liver Meeting® 2024

INTEGRIS-PSC to be featured in an oral presentation on Monday, November 18 SOUTH SAN FRANCISCO, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage...

17 Oktober 2024
GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

04 Oktober 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.79-6.661045531211.8612.69510.9450057511.67531071CS
4-2.27-17.016491754113.3414.25510.9440346412.65424414CS
12-3.76-25.354012137614.8316.110.9451340613.46390368CS
26-1.4-11.226944667212.4716.110.2245944513.20165556CS
52-5.61-33.633093525216.6818.919910.2245669513.46344CS
1560.080.72793448589610.9936.643.96564029219.16795524CS
260-11.43-50.822.543.923.96546018619.80411836CS

PLRX - Frequently Asked Questions (FAQ)

What is the current Pliant Therapeutics share price?
The current share price of Pliant Therapeutics is US$ 11,07
How many Pliant Therapeutics shares are in issue?
Pliant Therapeutics has 60.853.623 shares in issue
What is the market cap of Pliant Therapeutics?
The market capitalisation of Pliant Therapeutics is USD 682,17M
What is the 1 year trading range for Pliant Therapeutics share price?
Pliant Therapeutics has traded in the range of US$ 10,22 to US$ 18,9199 during the past year
What is the PE ratio of Pliant Therapeutics?
The price to earnings ratio of Pliant Therapeutics is -4,18
What is the cash to sales ratio of Pliant Therapeutics?
The cash to sales ratio of Pliant Therapeutics is 426,54
What is the reporting currency for Pliant Therapeutics?
Pliant Therapeutics reports financial results in USD
What is the latest annual turnover for Pliant Therapeutics?
The latest annual turnover of Pliant Therapeutics is USD 1,58M
What is the latest annual profit for Pliant Therapeutics?
The latest annual profit of Pliant Therapeutics is USD -161,34M
What is the registered address of Pliant Therapeutics?
The registered address for Pliant Therapeutics is 850 NEW BURTON ROAD SUITE 201, DOVER, DELAWARE, 19904
What is the Pliant Therapeutics website address?
The website address for Pliant Therapeutics is pliantrx.com.
Which industry sector does Pliant Therapeutics operate in?
Pliant Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ASSTAsset Entities Inc
US$ 0,8998
(93,71%)
263,47M
DWTXDogwood Therapeutics Inc
US$ 3,18
(70,05%)
24,31M
USEGUS Energy Corp
US$ 3,74
(61,21%)
107,79M
DOGZDogness International Corporation
US$ 27,62
(52,60%)
1,95M
MYNAMynaric AG
US$ 0,6697
(50,83%)
3,72M
GOEVCanoo Inc
US$ 0,3748
(-72,24%)
41,46M
SHOTWSafety Shot Inc
US$ 0,1094
(-47,40%)
18,66k
ORKTOrangeKloud Technology Inc
US$ 0,7068
(-36,89%)
7,67M
HEPAHepion Pharmaceuticals Inc
US$ 0,3219
(-31,36%)
1,66M
WNWMeiwu Technology Company Ltd
US$ 0,2681
(-27,05%)
11,12M
GCTKGlucoTrack Inc
US$ 0,1226
(44,41%)
613,28M
CRKNCrown Electrokinetics Corporation
US$ 0,1121
(-10,32%)
392,52M
ASSTAsset Entities Inc
US$ 0,8998
(93,71%)
262,98M
RIMEAlgorhythm Holdings Inc
US$ 0,034599
(-16,83%)
230,08M
RGTIRigetti Computing Inc
US$ 13,97
(42,12%)
226,81M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
PLRX
Pliant Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten